Abstract
BackgroundNo standardized, evidence-based surveillance practices exist to guide and optimize recurrence detection in patients with cutaneous melanoma. ObjectiveTo determine the most high-yield positive review of systems for signaling recurrence in patients with cutaneous melanoma. MethodsThis retrospective cohort study assessed patients with a history of cutaneous melanoma and compared demographic and clinical characteristics, including a comprehensive review of systems, amongst those who developed recurrence and those who did not. ResultsA high-yield positive review of systems associated with cutaneous melanoma recurrence can be remembered using the mnemonic ‘ATLAS’: Appetite change, Tiredness, Lymph node enlargement, Abdominal pain, and Shortness of breath LimitationsRetrospective design, limited sample size, and variability in follow up time between recurrent and non-recurrent cohorts. ConclusionAny treating physician using this model may have a greater opportunity to detect recurrent cutaneous melanoma and improve outcomes while limiting cost and morbidity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.